Mesenchymal Stem Cell Treatment for Crohn’s Disease
According to the CDC, an estimated 3.1 million adults (1.3%) in the United States have been diagnosed with stem cell therapy for inflammatory bowel disease disease (IBD), which includes Crohn’s disease (CD) and ulcerative colitis. Characterized by abdominal pain, severe diarrhea, fatigue, medical weight loss programs, and malnutrition, CD is thought to be the result…
